Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) EPS (Basic) (2016 - 2025)

Pediatrix Medical (MD) has disclosed EPS (Basic) for 17 consecutive years, with $0.41 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 10.81% to $0.41 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.97, a 265.55% increase, with the full-year FY2025 number at $1.97, up 265.55% from a year prior.
  • EPS (Basic) was $0.41 for Q4 2025 at Pediatrix Medical, down from $0.85 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.85 in Q3 2025 to a low of -$1.84 in Q2 2024.
  • A 5-year average of $0.11 and a median of $0.31 in 2022 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): soared 1333.33% in 2021, then crashed 641.18% in 2024.
  • Pediatrix Medical's EPS (Basic) stood at $0.29 in 2021, then rose by 20.69% to $0.35 in 2022, then crashed by 528.57% to -$1.5 in 2023, then skyrocketed by 124.67% to $0.37 in 2024, then increased by 10.81% to $0.41 in 2025.
  • Per Business Quant, the three most recent readings for MD's EPS (Basic) are $0.41 (Q4 2025), $0.85 (Q3 2025), and $0.46 (Q2 2025).